Jerrold F. Rosenbaum
#127,918
Most Influential Person Now
Jerrold F. Rosenbaum's AcademicInfluence.com Rankings
Jerrold F. Rosenbaumphilosophy Degrees
Philosophy
#6074
World Rank
#9045
Historical Rank
Logic
#3267
World Rank
#4397
Historical Rank
Download Badge
Philosophy Biology
Why Is Jerrold F. Rosenbaum Influential?
(Suggest an Edit or Addition)Jerrold F. Rosenbaum's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. (2006) (2419)
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006) (1928)
- Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. (2000) (1452)
- Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. (2004) (933)
- Further evidence of association between behavioral inhibition and social anxiety in children. (2001) (629)
- Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006) (593)
- Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. (2003) (535)
- Stable behavioral inhibition and its association with anxiety disorder. (1992) (504)
- Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) (2003) (499)
- Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial (1998) (499)
- A 3-year follow-up of children with and without behavioral inhibition. (1993) (492)
- Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. (1990) (480)
- Residual symptoms in depressed patients who respond acutely to fluoxetine. (1999) (455)
- Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. (1989) (400)
- Anxiety disorders in major depression. (2000) (315)
- Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. (1988) (299)
- Folate, vitamin B12, and homocysteine in major depressive disorder. (1997) (294)
- A double-blind trial of bupropion versus desipramine for bipolar depression. (1994) (276)
- Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression. (2001) (266)
- Behavioral Inhibition in Preschool Children At Risk Is a Specific Predictor of Middle Childhood Social Anxiety: A Five-Year Follow-up (2007) (253)
- Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. (1996) (246)
- Behavioral inhibition (2021) (243)
- Behavioral Inhibition in Childhood: A Risk Factor for Anxiety Disorders (1993) (240)
- Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. (1993) (237)
- Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment. (1993) (236)
- Prophylactic estrogen in recurrent postpartum affective disorder (1995) (236)
- Major depressive subtypes and treatment response (1997) (225)
- Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. (1994) (223)
- Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial. (2010) (216)
- Timing of onset of antidepressant response with fluoxetine treatment. (2000) (212)
- Expressed emotion toward children with behavioral inhibition: associations with maternal anxiety disorder. (1997) (204)
- A controlled study of behavioral inhibition in children of parents with panic disorder and depression. (2000) (202)
- Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. (1998) (202)
- Fluoxetine-induced sexual dysfunction. (1990) (194)
- Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. (2005) (184)
- Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment (2003) (182)
- Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. (1997) (181)
- Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. (1992) (181)
- Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. (2007) (179)
- Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review (2013) (174)
- Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. (1995) (171)
- A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depression (1991) (164)
- Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. (2004) (159)
- Elevated Anxiety Sensitivity Index scores in patients with major depression: Correlates and changes with antidepressant treatment. (1995) (157)
- Further evidence of an association between behavioral inhibition and anxiety disorders: Results from a family study of children from a non-clinical sample (1991) (156)
- Psychotropic drug use during pregnancy: weighing the risks. (1998) (155)
- The Corticotropin-Releasing Hormone Gene and Behavioral Inhibition in Children at Risk for Panic Disorder (2005) (155)
- "Anger attacks": possible variants of panic and major depressive disorders. (1990) (154)
- A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. (2000) (154)
- Changes in weight during a 1-year trial of fluoxetine. (1999) (153)
- Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. (1998) (152)
- Amitriptyline in the Treatment of Anorexia Nervosa: A Double‐Blind, Placebo‐Controlled Study (1985) (151)
- Influence of RGS2 on anxiety-related temperament, personality, and brain function. (2008) (147)
- Associations between expressed emotion and child behavioral inhibition and psychopathology: a pilot study. (1997) (147)
- Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. (2000) (145)
- Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine (2002) (142)
- A Double-blind, Randomized Trial of St John's Wort, Fluoxetine, and Placebo in Major Depressive Disorder (2005) (138)
- Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition (2003) (138)
- Postpartum obsessive compulsive disorder: a case series. (1993) (136)
- Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. (1989) (135)
- Anger attacks in depressed outpatients and their response to fluoxetine (1998) (134)
- Sensitivity of the six‐item Hamilton Depression Rating Scale (1997) (134)
- A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. (1993) (131)
- Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. (1996) (129)
- Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review (2000) (129)
- Fluoxetine efficacy in menopausal women with and without estrogen replacement. (1999) (127)
- Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications (1997) (124)
- Pharmacological approaches to the challenge of treatment-resistant depression (2015) (123)
- Behavioral inhibition in children: a possible precursor to panic disorder or social phobia. (1991) (119)
- Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. (2004) (119)
- Gender differences in personality disorders. (1995) (116)
- Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. (1996) (116)
- Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. (1991) (115)
- Anger attacks in patients with depression. (1999) (115)
- Course and treatment of atypical depression. (1998) (115)
- Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. (2000) (114)
- Childhood history of anxiety disorders among adults with social phobia: Rates, correlates, and comparisons with patients with panic disorder (2001) (114)
- Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. (2003) (114)
- Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. (1997) (113)
- National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. (2002) (112)
- Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study (1997) (112)
- Behavioral inhibition and disinhibition as hypothesized precursors to psychopathology: implications for pediatric bipolar disorder (2003) (111)
- Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. (1998) (109)
- Attention deficit hyperactivity disorder in childhood among adults with major depression (1996) (109)
- Behavioral inhibition as a risk factor for anxiety disorders. (1995) (105)
- Comorbidity of parental anxiety disorders as risk for childhood-onset anxiety in inhibited children. (1992) (105)
- Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. (1990) (102)
- Postpartum Prophylaxis for Women With Bipolar Disorder (1995) (102)
- Executive functioning in offspring at risk for depression and anxiety (2009) (100)
- Hypochondriacal concerns, anxiety sensitivity, and panic disorder (1992) (99)
- Risk factors for fatal and nonfatal repetition of suicide attempt: a critical appraisal (2010) (96)
- Personality and bipolar disorder: dissecting state and trait associations between mood and personality (2010) (95)
- Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. (2001) (95)
- When should a trial of fluoxetine for major depression be declared failed? (2003) (94)
- Obesity among outpatients with major depressive disorder. (2005) (93)
- The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. (2004) (93)
- Suicidality and fluoxetine: is there a relationship? (1991) (93)
- Cognitive behavior therapy for treatment-refractory panic disorder. (1994) (93)
- Clinical management of antidepressant discontinuation. (1997) (92)
- Hypothyroidism and hyperthyroidism in major depression revisited. (1995) (92)
- The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. (2005) (90)
- The child behavior checklist broad-band scales predict subsequent psychopathology: A 5-year follow-up. (2008) (89)
- Psychodynamic psychotherapy research : evidence-based practice and practice-based evidence (2012) (89)
- Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. (1996) (89)
- Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians (2000) (88)
- Personality disorder comorbidity with major depression and response to fluoxetine treatment. (1994) (88)
- Psychopathology in the young offspring of parents with bipolar disorder: A controlled pilot study (2006) (86)
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2008) (85)
- Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. (1992) (85)
- Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. (1998) (85)
- Treatment guidelines for psychotropic drug use in pregnancy. (1989) (83)
- Anger attacks in depression (1998) (83)
- Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. (1996) (81)
- Fenfluramine challenge in unipolar depression with and without anger attacks (2000) (81)
- The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. (2008) (80)
- Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. (1993) (78)
- Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. (2004) (78)
- Fluoxetine treatment of cocaine abuse in heroin addicts. (1991) (77)
- Outcome Definitions and Predictors in Depression (1998) (75)
- Treatment-Associated Suicidal Ideation and Adverse Effects in an Open, Multicenter Trial of Fluoxetine for Major Depressive Episodes (2006) (75)
- Emergence of hostility during alprazolam treatment. (1984) (75)
- A survey of prescribing practices in the treatment of depression (2002) (74)
- Cardiovascular risk factors in depression. The role of anxiety and anger. (1996) (71)
- Further evidence of an association between behavioral inhibition and anxiety disorders: results from a family study of children from a non-clinical sample. (1991) (71)
- Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. (1988) (70)
- Management of antidepressant-induced side effects: a practical guide for the clinician. (1987) (70)
- Prevalence of panic in patients referred for pulmonary function testing at a major medical center. (1996) (70)
- Temperamental correlates of disruptive behavior disorders in young children: preliminary findings (2002) (69)
- A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. (1997) (68)
- Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. (1996) (68)
- Tryptophan depletion in SSRI-recovered depressed outpatients (2001) (68)
- Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder (1999) (68)
- Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. (2002) (67)
- Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. (1997) (67)
- Developmental trajectories of anxiety disorders in offspring at high risk for panic disorder and major depression (2007) (66)
- Course of panic disorder during pregnancy and the puerperium: A preliminary study (1996) (66)
- Fluoxetine Versus Trazodone in Depressed Geriatric Patients (1989) (65)
- Treatment of panic disorder and agoraphobia with clonazepam. (1986) (65)
- Gender differences in Axis I comorbidity among depressed outpatients. (1996) (64)
- Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. (1999) (63)
- The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists (2002) (62)
- Attitudes toward benzodiazepines over the years. (2005) (62)
- Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose. (1995) (62)
- Vagus nerve stimulation for treatment-resistant depression (2000) (61)
- Transitional aged youth: a new frontier in child and adolescent psychiatry. (2013) (61)
- Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study (2016) (60)
- Premenstrual exacerbation of symptoms in women with panic disorder (1994) (60)
- Serum lithium levels and psychosocial function in patients with bipolar I disorder. (1996) (60)
- A controlled longitudinal 5-year follow-up study of children at high and low risk for panic disorder and major depression (2006) (60)
- Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. (2000) (59)
- The Human Ortholog of Acid-Sensing Ion Channel Gene ASIC1a Is Associated With Panic Disorder and Amygdala Structure and Function (2014) (59)
- Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression. (1999) (59)
- Impact of pregnancy on panic disorder: a case series. (1994) (58)
- Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. (1999) (58)
- The drug treatment of anxiety. (1982) (58)
- Alcohol dependence in panic disorder patients. (1992) (57)
- Dysfunctional attitudes in major depression. Changes with pharmacotherapy. (1994) (57)
- Genetic association analysis of behavioral inhibition using candidate loci from mouse models. (2001) (57)
- Childhood psychopathology retrospectively assessed among adults with early onset major depression. (1994) (56)
- Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. (1999) (56)
- Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. (1992) (55)
- Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. (1994) (55)
- Norms for depressed patients for the California verbal learning test: associations with depression severity and self-report of cognitive difficulties. (1994) (55)
- Body dysmorphic disorder in outpatients with major depression. (2002) (55)
- Variability of brain lithium levels during maintenance treatment: A magnetic resonance spectroscopy study (1995) (54)
- Postpartum onset of obsessive-compulsive disorder. (1993) (54)
- Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. (1986) (54)
- Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment. (1993) (54)
- Psychopathology in adolescent offspring of parents with panic disorder, major depression, or both: a 10-year follow-up. (2012) (54)
- The etiology of social phobia. (1994) (53)
- Postpartum course in women with preexisting panic disorder. (1994) (53)
- Pregnancy complications associated with childhood anxiety disorders (2004) (52)
- Eating disorder symptomatology in major depression. (1997) (52)
- Postpartum prophylaxis for women with bipolar disorder. (1996) (52)
- The alprazolam to clonazepam switch for the treatment of panic disorder. (1987) (51)
- Placebo response in depression (2002) (50)
- Assuring that double-blind is blind. (2010) (48)
- Fluoxetine treatment of anger attacks: a replication study. (1996) (48)
- Treatment resistant depression and Axis I co-morbidity (2001) (47)
- Differentiating social phobia and panic disorder: A test of core beliefs (1995) (47)
- Clonazepam: new uses and potential problems. (1987) (46)
- Gender Differences in Hostility Among Depressed and Medical Outpatients (1995) (46)
- Research Designs and Methods in Psychiatry (1992) (46)
- Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. (2006) (46)
- Challenges in clinical practice : pharmacologic and psychosocial strategies (1996) (45)
- Tricyclic Augmentation of Fluoxetine (1991) (44)
- Dichotic Listening before and after Fluoxetine Treatment for Major Depression: Relations of Laterality to Therapeutic Response (1996) (44)
- Laboratory-observed behavioral disinhibition in the young offspring of parents with bipolar disorder: a high-risk pilot study. (2006) (43)
- Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? (1996) (43)
- Treatment-resistant panic disorder. (1997) (42)
- Selecting methodologies for the evaluation of differences in time to response between antidepressants. (2002) (42)
- Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. (1993) (41)
- Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. (1987) (41)
- Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants. (2008) (40)
- Measurement of human brain lithium in vivo by MR spectroscopy. (1993) (40)
- Obstetrical and Neonatal Outcome following Clonazepam Use during Pregnancy: A Case Series (2001) (40)
- Blood pressure changes during short-term fluoxetine treatment. (1999) (39)
- Sleep panic attacks: An association with childhood anxiety and adult psychopathology (1994) (39)
- Anxiety disorders of childhood, Implications for adult psychopathology. (1995) (39)
- Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients. (1992) (39)
- Changes in adverse events reported by patients during 6 months of fluoxetine therapy. (1999) (39)
- Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. (1998) (38)
- Patterns of improvement in depressive symptoms with fluoxetine treatment. (1995) (38)
- Life Event, Mood, and Cognitive Predictors of Perceived Stress Before and After Treatment for Major Depression (1997) (38)
- Lack of association between behavioral inhibition and psychosocial adversity factors in children at risk for anxiety disorders. (2004) (37)
- High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine. (1992) (37)
- Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks. (1999) (36)
- Screening for dysfunction in the children of outpatients at a psychopharmacology clinic. (1991) (36)
- Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder (1989) (36)
- Clonazepam for the treatment of social phobia. (1990) (36)
- Serum cholesterol and serotonergic function in major depressive disorder (2003) (36)
- Hostility changes following antidepressant treatment: relationship to stress and negative thinking. (1996) (36)
- Propranolol and depression revisited: three cases and a review. (1985) (36)
- Cocaine abuse and treatment. (1989) (34)
- Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders (1993) (34)
- Hypochondriacal Concerns in Depressed Outpatients (1996) (34)
- Hemispheric laterality and memory bias for threat in anxiety disorders. (1994) (34)
- Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day (2003) (34)
- Panic attack-associated placental abruption: a case report. (1989) (33)
- Verapamil in the treatment of recurrent unipolar depression (1987) (33)
- Successful Use of Clonazepam in Patients with Treatment-Resistant Panic Disorder (1986) (33)
- Treatment-Resistant Depression and Axis II Comorbidity (2002) (32)
- Current status of pharmacotherapy for PTSD: An effect size analysis of controlled studies (1996) (32)
- Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. (1990) (31)
- Are study dropouts different from completers? (1996) (31)
- Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. (1999) (31)
- Clinical Outcomes of Laboratory-Observed Preschool Behavioral Disinhibition at Five-Year Follow-up (2007) (29)
- Outpatients with DSM-III-R versus DSM-IV melancholic depression. (1996) (28)
- An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. (1988) (28)
- Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. (1994) (28)
- Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression. (2004) (28)
- Phototherapy for seasonal affective disorder: a blind comparison of three different schedules. (1994) (26)
- Axis III disorders in treatment-resistant major depressive disorder (2003) (26)
- Health economics of depression (1993) (26)
- Does referral bias impact findings in high-risk offspring for anxiety disorders? A controlled study of high-risk children of non-referred parents with panic disorder/agoraphobia and major depression. (2004) (26)
- Fluoxetine treatment of depressed patients with comorbid anxiety disorders (2002) (26)
- Massachusetts General Hospital Comprehensive Clinical Psychiatry (2015) (26)
- TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. (1996) (25)
- Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. (1989) (25)
- Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder. (1986) (25)
- Clinical issues in the long-term treatment of panic disorder. (1996) (25)
- Efficacy of venlafaxine in the treatment of severe depression (2000) (25)
- Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample (2005) (24)
- Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. (1987) (24)
- Costs of Depressive Disorders: A Review (2001) (24)
- Childhood History of Anxiety in Adults with Panic Disorder: Association with Anxiety Sensitivity and Comorbidity (1994) (24)
- Childhood antecedents to panic disorder in referred and nonreferred adults. (2005) (24)
- Behavioral and Emotional Disturbances in the Offspring of Depressed Parents with Anger Attacks (2003) (23)
- Escitalopram: A Second-Generation SSRI (2002) (22)
- Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. (2002) (22)
- Panic disorder in emergency ward patients with chest pain. (1997) (22)
- Hypercapneic ventilatory response in patients with panic disorder before and after alprazolam treatment and in pre- and postmenstrual women. (1994) (22)
- Proton mrs of the basal ganglia in major depression Harvard Consolidated Department of Psychiatry, Belmont, MA 02178 (1994) (22)
- Clonazepam in the treatment of panic disorder and agoraphobia. (1987) (22)
- Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. (1990) (21)
- Moderating effects of major depression on patterns of comorbidity in patients with panic disorder (2004) (21)
- Correlations between perceived stress and depressive symptoms among depressive outpatients (1992) (20)
- Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. (2007) (20)
- Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo. (2005) (19)
- Benzodiazepines in panic-related disorders (1988) (19)
- A survey of prescribing preferences in the treatment of refractory depression: recent trends. (2001) (19)
- Cell‐surface expression of L‐selectin (CD62L) by blood lymphocytes: Correlates with affective parameters and severity of panic disorder (2000) (19)
- Major depression in panic disorder patients with comorbid social phobia. (1991) (18)
- Influence of phototherapy treatment duration for seasonal affective disorder: Outcome at one vs. two weeks (1995) (18)
- Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high‐risk offspring (2005) (18)
- Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice. (1999) (18)
- Perceptual asymmetry, plasma cortisol, and response to treatment in depressed outpatients (1991) (17)
- Drug interactions in psychopharmacology. (1993) (17)
- Psychiatrists, mental illness, and violence. (2007) (17)
- Teaching ethics of psychopharmacology research in psychiatric residency training programs (2003) (17)
- Algorithm for the treatment of panic disorder with agoraphobia. (1995) (17)
- Disruptive behavior disorders in offspring of parents with major depression: associations with parental behavior disorders. (2008) (17)
- Antecedents to panic disorder in nonreferred adults. (2006) (16)
- Anhedonic Ejaculation with Desipramine (1989) (16)
- Long-Term Use of Fluoxetine in Bulimia Nervosa: A Retrospective Study (1990) (15)
- Conflict of interest-- an issue for every psychiatrist. (2009) (15)
- Panic Disorder and Its Treatment (1998) (15)
- Calcium channel blockers in psychiatry. (1987) (15)
- Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders. (2005) (15)
- Managing Selective Serotonin Reuptake Inhibitor-Drug Interactions in Clinical Practice (1995) (15)
- Behavioral inhibition in childhood predicts smaller hippocampal volume in adolescent offspring of parents with panic disorder (2015) (15)
- Clonazepam vs. neuroleptics as adjuncts to lithium maintenance. (1990) (14)
- The development of clonazepam as a psychotropic: the massachusetts general hospital experience. (2004) (14)
- Social adjustment does not predict depressive relapse during continuation fluoxetine therapy. (1995) (14)
- Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. (2002) (14)
- Influence of RGS 2 on Anxiety-Related Temperament , Personality , and Brain Function (2008) (14)
- Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. (2004) (14)
- Lack of association between parental alcohol or drug addiction and behavioral inhibition in children. (2001) (13)
- Cynicism, hostility, and suicidal ideation in depressed outpatients. (1996) (13)
- Limited-symptom panic attacks (1987) (13)
- The use of natural remedies in psychiatry: a commentary. (1999) (13)
- Levy RA, Ablon JS, Kächele H (Hrsg) Psychodynamic psychotherapy research: evidence-based practice and practice-based evidence (2012) (12)
- Pattern of placebo response in panic disorder. (1995) (12)
- Transfer to a New Psychopharmacologist (2000) (12)
- Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder (2003) (12)
- Are thymoleptic-responsive "anger attacks" a discrete clinical syndrome? (1993) (12)
- Orthostatic hypotension and antidepressant pharmacotherapy. (1987) (11)
- Comprar Massachusetts General Hospital Comprehensive Clinical Psychiatry | Scott Rauch | 9780323047432 | Mosby (2008) (11)
- It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
- The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. (1994) (9)
- The Mini-Mental State Examination among adult outpatients with major depressive disorder. (1995) (9)
- Psychopharmacology of Pathologic Aggression (1993) (9)
- Nine Psychiatric Inpatients who Leaped from a Height* (1984) (9)
- Recognition and management of panic disorder. (1993) (9)
- Marijuana-related anxiety: a questionnaire based pilot study of normal and psychiatric populations (1988) (8)
- A High-risk Study of Young Children of Parents with Panic Disorder and Agoraphobia with and without Comorbid Major Depression (1992) (8)
- Cocaine and panic disorder. (1986) (8)
- The relationship between age and personality disorders in depressed outpatients. (1995) (7)
- Psychopathology in Children of Late versus Early Onset Bipolar Probands (1994) (7)
- Personality style and sexual functioning among psychiatric outpatients (1977) (7)
- Fluoxetine and norfluoxetine plasma levels in major depression (1995) (7)
- A comparison of symptoms following treatment interruption: Evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine (1998) (7)
- Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy. (2001) (6)
- Transmethylation and the central nervous system (1994) (6)
- Utilizing benzodiazepines in clinical practice: an evidence-based discussion. (2004) (6)
- Recurrent Depression, Resistant Clinician? (1998) (6)
- Chapter 18 – Psychopharmacologic Issues in the Medical Setting (2004) (6)
- Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression (2000) (6)
- Women's Health and Psychiatry (2002) (6)
- Prescribing lithium for pregnant women. (1988) (6)
- Are Dependency and Self-Criticism Risk Factors for Major Depressive Disorder? (1997) (6)
- Pramipexole treatment for cocaine cravings. (1999) (5)
- The influence of DST and TRH test administration on depression assessments: A controlled study (1993) (5)
- Treatment-emergent incontinence with lithium. (1985) (5)
- Treatment of outpatients with desipramine. (1984) (4)
- New uses for clonazepam in psychiatry: introduction and overview. (1987) (4)
- A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an ssri with those on no recent antidepressant treatment (2004) (4)
- State of the Art Panic Anxiety, Dyspnea, and Respiratory Disease Theoretical and Clinical Considerations (1996) (4)
- An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. (1988) (4)
- Benzodiazepines: A Perspective. (2020) (4)
- Erratum: The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine (International Journal of Neuropsychopharmacology (2005) DOI: 10.1017/S1461145705005195) (2005) (4)
- Preface Transmethylation and the central nervous system (1994) (4)
- Comorbidity of parental anxiety disorders as risk for childhood-onset anxiety in inhibited children Joseph Biederman, Jerrold F. Rosenbaum, Elizabeth A. Bolduc, Dina R. Hirshfeld, Stephen V. Faraone, Jerome Kagan Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 (1992) (4)
- Depression and its subtypes: a treatment update. Conclusion. (1998) (4)
- Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. (1995) (4)
- Methodological Challenges of Moving Beyond DSM Categories: Transdiagnostic Studies of Frontolimbic Connectivity Changes in Vulnerable Individuals (2013) (3)
- Introduction: early onset of antidepressant action. (2001) (3)
- Clinical Handbook of Anxiety Disorders: From Theory to Practice (2020) (3)
- Childhood Antecedents of Adult Anxiety Disorders (2007) (3)
- Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. (2013) (3)
- P-2-84 A pilot study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia (1995) (3)
- Phrenotropics: Makeup for the Mind? (1994) (3)
- Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy study. (1987) (3)
- Birth outcomes in pregnant women taking fluoxetine. (1997) (3)
- How to write a study protocol : a primer for the clinician (1992) (3)
- P-5-17 Predictors of time to relapse in a longitudinal study of panic disorder (1995) (3)
- P.4.a.009 Developmental trajectories of anxiety disorders in offspring at high risk for panic disorder (2006) (2)
- Switching patients from alprazolam to clonazepam. (1990) (2)
- Separating discontinuation symptoms from relapse (1999) (2)
- Conclusion/Depression and Its Subtypes: A Treatment Update (1998) (2)
- Hormonal Therapies for Psychiatric Symptoms in Women: Possibilities and Cautions (1994) (2)
- Pilot outreach services to homebound agoraphobic patients. (1991) (2)
- Fluoxetine versus sertraline and paroxetine in major depression: Long‐term changes in weight (2000) (2)
- 34 – Psychopharmacology in the Medical Setting (2011) (2)
- Acute distress after switch from Norpramin to generic desipramine. (1989) (2)
- Cognitive-Behavioral Strategies to Manage Panic Disorder (2021) (2)
- Massachusetts General Hospital Psychopharmacology and Neurotherapeutics (2015) (2)
- The course and treatment of manic-depressive illness: an update. (1988) (2)
- he Corticotropin-Releasing Hormone Gene and ehavioral Inhibition in Children at Risk for Panic (2005) (1)
- 342. Fluoxetine versus sertraline and paroxetine in major depression: Safety and efficacy in anxious and nonanxious subgroups (1998) (1)
- Development of human anxiety (1995) (1)
- Anxiety Treatment With Benzodiazepines. (2021) (1)
- Conclusion: The Future of Single-Isomer Pharmacology (2002) (1)
- Comprar Natural Medications for Psychiatric Disorders 2/e | David Mischoulon MD, PhD | 9780781767620 | Lippincott Williams & Wilkins (2008) (1)
- Introduction/Depression and Its Subtypes: A Treatment Update (1998) (1)
- Fluoxetine versus sertraline and paroxetine in major depression: Efficacy and tolerability in patients with high or low baseline insomnia (1998) (1)
- Drug treatment of panic disorder. (1990) (1)
- 13 – Anxious Patients (2010) (1)
- Contents of the American Journal of Psychiatry (1992) (0)
- Depression and its subtypes: a treatment update. Introduction. (1998) (0)
- Mental illness, violence and the gun control debate: evidence, policy, privacy and stigma-on behalf of the ACNP Ethics Committee (2013) (0)
- Erratum: Measurement of human brain lithium in vivo by MR spectroscopy (American Journal of Neuroradiology (September/October 1993)) (1993) (0)
- The Psychiatric Morbidity and Mortality Teaching Conference to Improve Patient Safety: Lessons Learned at the Massachusetts General Hospital (2017) (0)
- Limited-symptom panic attacks. (1988) (0)
- S-17-3 Benzodiazepines in panic disorders: Focus on clonazepam (1995) (0)
- Imipramine equivalents. Reply (1990) (0)
- Dr. Fava and Colleagues Reply (1995) (0)
- In Memoriam: Joseph Biederman, MD, 1947-2023. (2023) (0)
- A third view on benzodiazepines and sleep latency. (1985) (0)
- Reducing Your Risk of Bipolar Disorder (2011) (0)
- Depressions of Milder Severity: Listening to Data (1996) (0)
- Psychopharmacology of Anxiety (1991) (0)
- Temperamental risk factors for anxiety disorders in high risk children (2002) (0)
- Contents of The American Journal of Psychiatry (2004) (0)
- 341. Fluoxetine versus sertraline and paroxetine in major depression: Safety and efficacy in patients with low and high baseline insomnia (1998) (0)
- Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder (1990) (0)
- We've Got Issues: Children and Parents in the Age of Medication (2011) (0)
- Contents, Vol. 62, 1994 (1994) (0)
- Recollections from the ADAA President (2011) (0)
- Drug therapy: predictors of response (2003) (0)
- Clonazepam and other anticonvulsants (1990) (0)
- Linking Panic Disorder and Depression: the Fatigue Dimension (1991) (0)
- Depression and Its Subtypes: A Treatment Update (2015) (0)
- In Memoriam (2002) (0)
- S-5-2 Treatment response to serotonin reuptake inhibitors in minor depressions (1995) (0)
- Book Review / Announcements (2002) (0)
- Update on trends in antidepressant use: Upswing in 2006 Following Period of Decline. (2006) (0)
- Brain lithium levels measured by MRS: Variability during maintenance treatment in bipolar disorder (1994) (0)
- Dr. Amsterdam and Colleagues Reply (1998) (0)
- Expanding the use of anxiolytics in clinical practice (2000) (0)
- Chapter 15 – Anxious Patients (2004) (0)
- FLUOXETINE AND NORFLUOXETINE. AUTHORS' REPLY (1998) (0)
- P.0035 Structural brain correlates of childhood inhibited temperament: rationale and methodology for an ENIGMA-Anxiety mega-analysis (2021) (0)
- Essentials of Neuroimaging for Clinical Practice: E-Book (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jerrold F. Rosenbaum?
Jerrold F. Rosenbaum is affiliated with the following schools:
